ArticleSignal transduction and targeted therapy2026
Transcriptional intermediary factor 1 gamma-based multitarget gene therapeutic strategy for triple-negative breast cancer.
Hyomin Park et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.